Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial
Benjamin A. Fisher(Birmingham City University), K Turner, Tony Whitehouse(Queen Elizabeth Hospital Birmingham), Tonny Veenith(New Cross Hospital), Nicholas Morley(Royal Hallamshire Hospital), Brian Angus(University of Oxford), Vincenzo Libri, Charlotte Gaskell(Cancer Research UK Clinical Trials Unit), Peter Watkinson(University of Oxford), Camilla Bathurst, Alex Richter, Karen James(Cancer Research UK Clinical Trials Unit), Bryan Williams(The London College), Susie Mee, Sian Faustini(University of Birmingham), Joseph Van de Wiel, Elizabeth Sapey(University Hospitals Birmingham NHS Foundation Trust), Bushra Rahman, David Thickett(Centre for Inflammation Research), Julian Bion(Clinical Trial Investigators), Rebecca Turner(University of Manchester), Gary Middleton(University Hospitals Birmingham NHS Foundation Trust), Matthew Rowland(University of Oxford), Alexander J. Mentzer(Centre for Human Genetics), Dhruv Parekh(University Hospitals Birmingham NHS Foundation Trust), Mark R. Thomas(University of Leeds), Philip N. Newsome(King's College London), Mark Coles(University of Oxford), James Scriven(University Hospitals Birmingham NHS Foundation Trust), Rowena Sharpe(Cancer Research UK Clinical Trials Unit), Duncan Richards(University of Oxford), Francis Mussai, Pamela Kearns(National Institute for Health and Care Research), S. Bowden(Cancer Research UK Clinical Trials Unit), Matt P. Wise(University Hospital of Wales), Alex Novak, Daniel Slade(Temple University), Mansoor N. Bangash, Joanna C. Porter(University College Hospital), Anna Rowe(University Hospitals Birmingham NHS Foundation Trust), Ling‐Pei Ho(University of Oxford), Helen McShane(University of Oxford), Madhu Balasubramaniam(Royal Bolton Hospital), Simon Gates(Oxford Brookes University), Marc D. Feldman(UCLA Health), G Cooke, Zoë Gabriel(Sheffield Teaching Hospitals NHS Foundation Trust), Naj Rahman, Fang Gao Smith(University Hospitals Birmingham NHS Foundation Trust), Jaimin Patel
UCL Discovery (University College London)
January 1, 2022
Cited by 58
Related Papers
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
|Intensive Care Medicine|2007|4.9k
Interventions for preventing falls in older people living in the community
|Cochrane Database of Systematic Reviews|2012|3.9k